83 FR 24802 - Agency Information Collection Activities; Submission for OMB Review; Comment Request

FEDERAL TRADE COMMISSION

Federal Register Volume 83, Issue 104 (May 30, 2018)

Page Range		24802-24803
FR Document		2018-11503
In compliance with the Paperwork Reduction Act (PRA) of 1995, the FTC is seeking public comments on its request to OMB to extend for three years the current PRA clearances for information collection requirements contained in the Commission's rules and regulations under the Fur Products Labeling Act (Fur Rules or Rules). The clearance expires on May 31, 2018.
Federal Register, Volume 83 Issue 104 (Wednesday, May 30, 2018)
[Federal Register Volume 83, Number 104 (Wednesday, May 30, 2018)]
[Notices]
[Pages 24802-24803]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-11503]



[[Page 24802]]

=======================================================================
-----------------------------------------------------------------------

FEDERAL TRADE COMMISSION


Agency Information Collection Activities; Submission for OMB 
Review; Comment Request

AGENCY: Federal Trade Commission (FTC).

ACTION: Notice and request for comment.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act (PRA) of 1995, 
the FTC is seeking public comments on its request to OMB to extend for 
three years the current PRA clearances for information collection 
requirements contained in the Commission's rules and regulations under 
the Fur Products Labeling Act (Fur Rules or Rules). The clearance 
expires on May 31, 2018.

DATES: Comments must be received by June 29, 2018.

ADDRESSES: Interested parties may file a comment online or on paper by 
following the instructions in the Request for Comments part of the 
SUPPLEMENTARY INFORMATION section below. Write ``Fur Rules: FTC File 
No. P072108'' on your comment, and file your comment online at https://ftcpublic.commentworks.com/ftc/furrulespra2 by following the 
instructions on the web-based form. If you prefer to file your comment 
on paper, mail your comment to the following address: Federal Trade 
Commission, Office of the Secretary, 600 Pennsylvania Avenue NW, Suite 
CC-5610 (Annex J), Washington, DC 20580, or deliver your comment to the 
following address: Federal Trade Commission, Office of the Secretary, 
Constitution Center, 400 7th Street SW, 5th Floor, Suite 5610 (Annex 
J), Washington, DC 20024.

FOR FURTHER INFORMATION CONTACT: Requests for additional information or 
copies of the proposed information requirements should be addressed to 
Jock K. Chung, Attorney, Division of Enforcement, Bureau of Consumer 
Protection, Federal Trade Commission, Mail Code CC-9528, 600 
Pennsylvania Ave. NW, Washington, DC 20580, (202) 326-2984.

SUPPLEMENTARY INFORMATION: 
    Title: Rules and regulations under the Fur Products Labeling Act, 
16 CFR part 301.
    OMB Control Number: 3084-0099.
    Type of Review: Extension of a currently approved collection.
    Abstract: The Fur Products Labeling Act (Fur Act) \1\ prohibits the 
misbranding and false advertising of fur products. The Fur Rules 
establish disclosure requirements that assist consumers in making 
informed purchasing decisions, and recordkeeping requirements that 
assist the Commission in enforcing the Rules. The Rules also provide a 
procedure for exemption from certain disclosure provisions under the 
Fur Act.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 69 et seq.
---------------------------------------------------------------------------

    On March 9, 2018, the Commission sought comment on the information 
collection requirements in the Fur Rules. 83 FR 10482. One germane 
comment was received.\2\ Mr. Morgan Williamson appears to opine that 
enforcement of the Fur Rules helps ensure that accurate information is 
provided to the public by the fur industry about whether fur is faux or 
not. Mr. Williamson does not however reference any of the PRA estimates 
associated with the 60-day Federal Register notice. As required by OMB 
regulations, 5 CFR part 1320, the FTC is providing this second 
opportunity for public comment.
---------------------------------------------------------------------------

    \2\ The Commission also received four non-germane comments.
---------------------------------------------------------------------------

    Likely Respondents: Retailers, manufacturers, processors, and 
importers of furs and fur products.
    Frequency of Response: Third party disclosure; recordkeeping 
requirement.
    Estimated Annual Hours Burden: 249,541 hours (64,440 hours for 
recordkeeping + 185,101 hours for disclosure).
    Recordkeeping: 64,440 hours [1,230 retailers incur an average 
recordkeeping burden of about 18 hours per year (22,140 hours total); 
90 manufacturers incur an average recordkeeping burden of about 60 
hours per year (5,400 hours total); and 1,230 importers of furs and fur 
products incur an average recordkeeping burden of 30 hours per year 
(36,900 hours total)]
    Disclosure: 185,101 hours [(107,585 hours for labeling + 28,316 
hours for invoices + 49,200 hours for advertising).]
    Estimated annual cost burden: $5,105,813 (solely relating to labor 
costs).\3\
---------------------------------------------------------------------------

    \3\ The estimated annual labor burden is slightly higher than 
the estimate of $4,996,243, which was cited in the 60-day Federal 
Register notice. The prior notice relied upon data from the Bureau 
of Labor Statistics Occupational Employment Statistics Survey as of 
May 2016, while this current Federal Register notice relies upon 
data from the March 30, 2018 BLS survey updated through May 2017.
---------------------------------------------------------------------------

Request for Comment

    You can file a comment online or on paper. For the FTC to consider 
your comment, we must receive it on or before June 29, 2018. Write 
``Fur Rules: FTC File No. P072108'' on your comment. Your comment--
including your name and your state--will be placed on the public record 
of this proceeding, including, to the extent practicable, on the public 
Commission website, at http://www.ftc.gov/os/publiccomments.shtm.
    Postal mail addressed to the Commission is subject to delay due to 
heightened security screening. As a result, we encourage you to submit 
your comments online, or to send them to the Commission by courier or 
overnight service. To make sure that the Commission considers your 
online comment, you must file it at https://ftcpublic.commentworks.com/ftc/furrulespra2 by following the instructions on the web-based form. 
When this Notice appears at http://www.regulations.gov, you also may 
file a comment through that website.
    If you file your comment on paper, write ``Fur Rules: FTC File No. 
P072108'' on your comment and on the envelope, and mail it to the 
following address: Federal Trade Commission, Office of the Secretary, 
600 Pennsylvania Avenue NW, Suite CC-5610 (Annex J), Washington, DC 
20580, or deliver your comment to the following address: Federal Trade 
Commission, Office of the Secretary, Constitution Center, 400 7th 
Street SW, 5th Floor, Suite 5610, Washington, DC 20024. If possible, 
submit your paper comment to the Commission by courier or overnight 
service.
    Comments on the information collection requirements subject to 
review under the PRA should additionally be submitted to OMB. If sent 
by U.S. mail, they should be addressed to Office of Information and 
Regulatory Affairs, Office of Management and Budget, Attention: Desk 
Officer for the Federal Trade Commission, New Executive Office 
Building, Docket Library, Room 10102, 725 17th Street NW, Washington, 
DC 20503. Comments sent to OMB by U.S. postal mail are subject to 
delays due to heightened security precautions. Thus, comments can also 
be sent via email to Wendy_L._Liberante@omb.eop.gov.
    Because your comment will be placed on the publicly accessible FTC 
website at https://www.ftc.gov, you are solely responsible for making 
sure that your comment does not include any sensitive or confidential 
information. In particular, your comment should not include any 
sensitive personal information, such as your or anyone else's Social 
Security number; date of birth; driver's license number or other state 
identification number, or foreign country equivalent; passport number; 
financial account number; or credit or debit card number. You are also 
solely

[[Page 24803]]

responsible for making sure that your comment does not include any 
sensitive health information, such as medical records or other 
individually identifiable health information. In addition, your comment 
should not include any ``trade secret or any commercial or financial 
information which . . . is privileged or confidential''--as provided by 
Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 
16 CFR 4.10(a)(2)--including in particular competitively sensitive 
information such as costs, sales statistics, inventories, formulas, 
patterns, devices, manufacturing processes, or customer names.
    Comments containing material for which confidential treatment is 
requested must be filed in paper form, must be clearly labeled 
``Confidential,'' and must comply with FTC Rule 4.9(c). In particular, 
the written request for confidential treatment that accompanies the 
comment must include the factual and legal basis for the request, and 
must identify the specific portions of the comment to be withheld from 
the public record. See FTC Rule 4.9(c). Your comment will be kept 
confidential only if the General Counsel grants your request in 
accordance with the law and the public interest. Once your comment has 
been posted on the public FTC website--as legally required by FTC Rule 
4.9(b)--we cannot redact or remove your comment from the FTC website, 
unless you submit a confidentiality request that meets the requirements 
for such treatment under FTC Rule 4.9(c), and the General Counsel 
grants that request.
    The FTC Act and other laws that the Commission administers permit 
the collection of public comments to consider and use in this 
proceeding as appropriate. The Commission will consider all timely and 
responsive public comments that it receives on or before June 29, 2018. 
For information on the Commission's privacy policy, including routine 
uses permitted by the Privacy Act, see https://www.ftc.gov/site-information/privacy-policy.

Heather Hippsley,
Acting Principal Deputy General Counsel.
[FR Doc. 2018-11503 Filed 5-29-18; 8:45 am]
 BILLING CODE 6750-01-P
Federal Register / Vol. 83, No. 104 / Wednesday, May 30, 2018 / Notices 24803

responsible for making sure that your DEPARTMENT OF HEALTH AND Place: National Institutes of Health, Two
comment does not include any sensitive HUMAN SERVICES Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
health information, such as medical
National Institutes of Health Conference Call).
records or other individually Contact Person: Najma S. Begum, Ph.D.,
identifiable health information. In Scientific Review Officer, Review Branch,
National Institute of Diabetes and
addition, your comment should not DEA, NIDDK, National Institutes of Health,
Digestive and Kidney Diseases; Notice Room 7349, 6707 Democracy Boulevard,
include any ‘‘trade secret or any of Closed Meetings
commercial or financial information Bethesda, MD 20892–5452, (301) 594–8894,
Pursuant to section 10(d) of the begumn@niddk.nih.gov.
which . . . is privileged or
Federal Advisory Committee Act, as Name of Committee: National Institute of
confidential’’—as provided by Section Diabetes and Digestive and Kidney Diseases
6(f) of the FTC Act, 15 U.S.C. 46(f), and amended, notice is hereby given of the
Special Emphasis Panel; Lymphatics in
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— following meetings. Health and Disease.
including in particular competitively The meetings will be closed to the Date: July 17, 2018.
sensitive information such as costs, public in accordance with the Time: 10:00 a.m. to 2:00 p.m.
sales statistics, inventories, formulas, provisions set forth in sections Agenda: To review and evaluate grant
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications.
patterns, devices, manufacturing Place: National Institutes of Health, Two
as amended. The grant applications and
processes, or customer names. Democracy Plaza, 6707 Democracy
the discussions could disclose
Comments containing material for confidential trade secrets or commercial Boulevard, Bethesda, MD 20892 (Telephone
which confidential treatment is Conference Call).
property such as patentable material, Contact Person: Michele L. Barnard, Ph.D.,
requested must be filed in paper form, and personal information concerning Scientific Review Officer, Review Branch,
must be clearly labeled ‘‘Confidential,’’ individuals associated with the grant DEA, NIDDK, National Institutes of Health,
and must comply with FTC Rule 4.9(c). applications, the disclosure of which Room 7353, 6707 Democracy Boulevard,
In particular, the written request for would constitute a clearly unwarranted Bethesda, MD 20892–2542, (301) 594–8898,
confidential treatment that accompanies invasion of personal privacy. barnardm@extra.niddk.nih.gov.
the comment must include the factual Name of Committee: National Institute of (Catalogue of Federal Domestic Assistance
and legal basis for the request, and must Diabetes and Digestive and Kidney Diseases Program Nos. 93.847, Diabetes,
identify the specific portions of the Special Emphasis Panel; NIDDK Clinical Endocrinology and Metabolic Research;
Trials in Diabetes. 93.848, Digestive Diseases and Nutrition
comment to be withheld from the public
Date: June 18, 2018. Research; 93.849, Kidney Diseases, Urology
record. See FTC Rule 4.9(c). Your and Hematology Research, National Institutes
Time: 9:00 a.m. to 10:00 a.m.
comment will be kept confidential only Agenda: To review and evaluate grant of Health, HHS)
if the General Counsel grants your applications. Dated: May 24, 2018.
request in accordance with the law and Place: National Institutes of Health, Two David D. Clary,
the public interest. Once your comment Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone Program Analyst, Office of Federal Advisory
has been posted on the public FTC Committee Policy.
website—as legally required by FTC Conference Call).
Contact Person: Elena Sanovich, Ph.D., [FR Doc. 2018–11560 Filed 5–29–18; 8:45 am]
Rule 4.9(b)—we cannot redact or Scientific Review Officer, Review Branch, BILLING CODE 4140–01–P
remove your comment from the FTC DEA, NIDDK, National Institutes of Health,
website, unless you submit a Room 7351, 6707 Democracy Boulevard,
confidentiality request that meets the Bethesda, MD 20892–2542, 301–594–8886, DEPARTMENT OF HEALTH AND
requirements for such treatment under sanoviche@mail.nih.gov. HUMAN SERVICES
FTC Rule 4.9(c), and the General Name of Committee: National Institute of
Counsel grants that request. Diabetes and Digestive and Kidney Diseases National Institutes of Health
Special Emphasis Panel; PAR–18–042:
The FTC Act and other laws that the Ancillary Studies to Major Ongoing Clinical National Heart, Lung, and Blood
Commission administers permit the Research Studies. Institute Notice of Closed Meeting
collection of public comments to Date: June 28, 2018.
consider and use in this proceeding as Time: 10:00 a.m. to 12:00 p.m. Pursuant to section 10(d) of the
appropriate. The Commission will Agenda: To review and evaluate grant Federal Advisory Committee Act, as
applications. amended, notice is hereby given of the
consider all timely and responsive Place: National Institutes of Health, Two
public comments that it receives on or following meeting of the NHLBI
Democracy Plaza, 6707 Democracy Institutional Training Mechanism
before June 29, 2018. For information on Boulevard, Bethesda, MD 20892 (Telephone Review Committee.
the Commission’s privacy policy, Conference Call).
The meeting will be closed to the
including routine uses permitted by the Contact Person: Dianne Camp, Ph.D.,
Scientific Review Officer, Review Branch, public in accordance with the
Privacy Act, see https://www.ftc.gov/ provisions set forth in sections
DEA, NIDDK, National Institutes of Health,
site-information/privacy-policy. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Room 7013, 6707 Democracy Boulevard,
Heather Hippsley, Bethesda, MD 20892–2542, 301–594–7682, as amended. The grant applications and
Acting Principal Deputy General Counsel.
campd@extra.niddk.nih.gov. the discussions could disclose
Name of Committee: National Institute of confidential trade secrets or commercial
[FR Doc. 2018–11503 Filed 5–29–18; 8:45 am]
Diabetes and Digestive and Kidney Diseases property such as patentable material,
sradovich on DSK3GMQ082PROD with NOTICES

BILLING CODE 6750–01–P Special Emphasis Panel; PAR–18–423: and personal information concerning
NIDDK Multi-Center Clinical Study individuals associated with the grant
Implementation Planning Cooperative applications, the disclosure of which
Agreements (U34 Clinical Trial Optional).
would constitute a clearly unwarranted
Date: July 2, 2018.
Time: 11:30 a.m. to 2:00 p.m. invasion of personal privacy.
Agenda: To review and evaluate Name of Committee: Heart, Lung, and
cooperative agreement applications. Blood Initial Review Group; NHLBI

VerDate Sep<11>2014 17:04 May 29, 2018 Jkt 244001 PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 E:\FR\FM\30MYN1.SGM 30MYN1
Document Created: 2018-05-30 01:01:29
Document Modified: 2018-05-30 01:01:29
Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice and request for comment.
Dates		Comments must be received by June 29, 2018.
Contact		Requests for additional information or
FR Citation		83 FR 24802